Ravi Narra in Toledo, Ohio

Medical School: Medical College Of Ohio
Graduation Year: 1999
The Primary Medical Specialty for Ravi Narra is listed as: Internal Medicine
Approximate Years of Experience: 25
PAC (PECOS ID)#: 6507996287
NPI #: 1033197017
NPI Created On: 01/09/2006
NPI Last Updated Listed as: 11/03/2023
Primary Taxonomy Code: 207R00000X
License Number:
390146700
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Paramount Insurance Company
• CareSource
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Hemoglobin a1c level
2. Vaccine for influenza for injection into muscle
3. Pneumococcal vaccine for injection into muscle
4. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Established patient office or other outpatient visit, typically 10 minutes
7. Established patient office or other outpatient visit, typically 15 minutes
8. Established patient office or other outpatient, visit typically 25 minutes
9. Established patient office or other outpatient, visit typically 40 minutes
10. Hospital observation care, typically 70 minutes
11. Initial hospital inpatient care, typically 70 minutes per day
12. Subsequent hospital inpatient care, typically 15 minutes per day
13. Subsequent hospital inpatient care, typically 25 minutes per day
14. Subsequent hospital inpatient care, typically 35 minutes per day
15. Hospital discharge day management, more than 30 minutes
16. Physician telephone patient service, 5-10 minutes of medical discussion
17. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
18. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
19. Administration of influenza virus vaccine
20. Administration of pneumococcal vaccine